These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10369989)

  • 21. Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.
    Byun BH; Kim SH; Lim SM; Lim I; Kong CB; Song WS; Cho WH; Jeon DG; Lee SY; Koh JS; Chung SK
    Eur Radiol; 2015 Jul; 25(7):2015-24. PubMed ID: 25680716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma].
    Huang ZK; Lou C; Shi GH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):183-7, 191. PubMed ID: 22499516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP scintigraphy in 34 cases.
    Kobayashi Y; Ozaki T; Takeda Y; Kawai A; Inoue H
    Acta Orthop Scand; 1998 Dec; 69(6):611-6. PubMed ID: 9930108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone scintigraphy in assessing the success of chemotherapy in osteosarcoma].
    Knop J; Stritzke P; Montz R; Delling G; Winkler K
    Nuklearmedizin; 1985 Apr; 24(2):75-81. PubMed ID: 2410864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extraskeletal osteosarcoma in the thigh: a case report.
    Kajihara M; Sugawara Y; Hirata M; Kikuchi K; Miki H; Mochizuki T; Sakayama K; Kidani T; Miyazaki T
    Radiat Med; 2005 Mar; 23(2):142-6. PubMed ID: 15827535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma.
    Stokkel MP; Linthorst MF; Borm JJ; Taminiau AH; Pauwels EK
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):393-9. PubMed ID: 12136254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis.
    Knop J; Delling G; Heise U; Winkler K
    Chir Organi Mov; 1990; 75(1 Suppl):36-7. PubMed ID: 2249552
    [No Abstract]   [Full Text] [Related]  

  • 30. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging.
    Sommer HJ; Knop J; Heise U; Winkler K; Delling G
    Cancer; 1987 Jan; 59(2):252-8. PubMed ID: 3467818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
    de Baere T; Vanel D; Shapeero LG; Charpentier A; Terrier P; di Paola M
    Radiology; 1992 Nov; 185(2):587-92. PubMed ID: 1410378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy.
    Torricelli P; Montanari N; Spina V; Manfrini M; Bertoni F; Saguatti G; Romagnoli R
    Radiol Med; 2001 Mar; 101(3):145-51. PubMed ID: 11402952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosis].
    Urso S; Pacciani E; Fariello G; Colajacomo M; Fassari FM; Randisi F; Certo A; Liberatore M; Pagnotta G
    Radiol Med; 1995 Sep; 90(3):212-8. PubMed ID: 7501824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy.
    Eftekhari F
    Cancer Treat Res; 2009; 152():33-62. PubMed ID: 20213385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
    Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
    BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis.
    Kubo T; Furuta T; Johan MP; Adachi N; Ochi M
    Skeletal Radiol; 2016 Sep; 45(9):1235-42. PubMed ID: 27229874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of dynamic MRI and clinical assessment in predicting histologic response to neoadjuvant chemotherapy in bone sarcomas.
    Amit P; Patro DK; Basu D; Elangovan S; Parathasarathy V
    Am J Clin Oncol; 2014 Aug; 37(4):384-90. PubMed ID: 23388556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intense gallbladder uptake associated with chemotherapy. An unusual finding in pediatric skeletal scintigraphy.
    Lowry PA; Carstens C
    Clin Nucl Med; 1995 Nov; 20(11):976-8. PubMed ID: 8565378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
    Cheon GJ; Kim MS; Lee JA; Lee SY; Cho WH; Song WS; Koh JS; Yoo JY; Oh DH; Shin DS; Jeon DG
    J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy.
    Hanna SL; Fletcher BD; Fairclough DL; Jenkins JH; Le AH
    Skeletal Radiol; 1991; 20(2):79-84. PubMed ID: 2020867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.